|
0
|
|
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.
(nature.com)
|
Kapulu MC
…
Bejon P
Nature Medicine
2026-01-01
|
#infection
#vaccination
#immunity
#malaria
|
|
0
|
|
Gene-drive-capable mosquitoes suppress patient-derived malaria in Tanzania.
(nature.com)
|
Habtewold T
…
Christophides GK
Nature
2026-01-01
|
#immunity
#malaria
#gene drive
#transgenic
#vectorial capacity
|
|
0
|
|
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial.
(linkinghub.elsevier.com)
|
Kamya MR
…
Yeka A
Lancet Infectious Diseases
2026-01-01
|
#amr
#malaria
#clinical trial
#treatment
#artemisinin
|
|
0
|
|
A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice.
(nature.com)
|
Shi D
…
Tolia NH
Nature Microbiology
2026-01-01
|
#nanoparticles
#vaccination
#immunity
#malaria
#antigen
|
|
0
|
|
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial.
(linkinghub.elsevier.com)
|
Agnandji ST
…
Mordmuller B
Lancet Infectious Diseases
2026-01-01
|
#vaccination
#malaria
#clinical trial
#immunology
|